STOCK TITAN

Stock option awards to Glimpse Group, Inc. (GGRP) former director

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Glimpse Group, Inc. reported that former director Jeffrey D. Enslin, through Perimetre Capital, LLC, acquired two stock option awards. On May 1, 2026 he received 54,375 options with a $0.6900 exercise price that vested immediately. On January 1, 2025 he received 37,500 options with a $2.2500 exercise price, vesting in equal monthly increments from January 31, 2025 through December 31, 2025. Both awards are exercisable into common stock and expire on May 15, 2031.

Positive

  • None.

Negative

  • None.
Insider Enslin Jeffrey D.
Role Insider
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2, F3 54,375 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F3 37,500 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 91,875 shares (Indirect, By Perimetre Capital, LLC)
Footnotes (3)
  1. F1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.
  2. F2. This option vested immediately upon grant.
  3. F3. Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin.
Option grant size 54,375 options Stock option grant to Perimetre Capital, LLC dated 2026-05-01
Exercise price $0.6900 per share Exercise price for 54,375-option award dated 2026-05-01
Option grant size 37,500 options Stock option grant to Perimetre Capital, LLC dated 2025-01-01
Exercise price $2.2500 per share Exercise price for 37,500-option award dated 2025-01-01
Expiration date 2031-05-15 Expiration for both reported stock option awards
Vesting period 1/31/2025–12/31/2025 Monthly vesting schedule for the 37,500-option grant
Stock Option (Right to Buy) financial
"Security title is shown as "Stock Option (Right to Buy)" for each award"
conversion or exercise price financial
"Each option grant discloses a specific "conversion or exercise price" per share"
indirect ownership financial
"Ownership type is reported as indirect ownership through Perimetre Capital, LLC"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stock options did Jeffrey D. Enslin receive from Glimpse Group (GGRP) on 2026-05-01?

On May 1, 2026, Jeffrey D. Enslin, via Perimetre Capital, LLC, was granted 54,375 stock options for Glimpse Group common stock at a $0.6900 exercise price. The options vested immediately upon grant and are scheduled to expire on May 15, 2031.

What earlier Glimpse Group (GGRP) stock option grant to Jeffrey D. Enslin is disclosed?

The filing shows a grant of 37,500 stock options on January 1, 2025, with a $2.2500 exercise price. This award vests in equal monthly increments from January 31, 2025 through December 31, 2025, and also expires on May 15, 2031.

How are Jeffrey D. Enslin’s Glimpse Group (GGRP) options held?

Both reported option awards are held indirectly through Perimetre Capital, LLC. A footnote states that Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin, so the options are attributed to that entity rather than to him personally.

Do the Glimpse Group (GGRP) option grants involve a Rule 10b5-1 trading plan?

The filing indicates the grants were not made under a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is explicitly unchecked, and there is no footnote stating that the transactions were executed pursuant to any pre-arranged trading arrangement.

When do Jeffrey D. Enslin’s Glimpse Group (GGRP) stock options expire?

Both the 54,375-option award and the 37,500-option award are scheduled to expire on May 15, 2031. This single expiration date applies to each grant, regardless of their different grant dates, exercise prices, and vesting schedules.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Enslin Jeffrey D.

(Last)(First)(Middle)
15 WEST 38TH ST
12TH FLOOR

(Street)
NEW YORK NEW YORK 10018

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Glimpse Group, Inc. [ GGRP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
Officer (give title below)XOther (specify below)
Former director
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
01/01/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$2.2501/01/2025A37,500 (1)05/15/2031Common Stock37,500$037,500IBy Perimetre Capital, LLC(3)
Stock Option (Right to Buy)$0.6905/01/2026A54,375 (2)05/15/2031Common Stock54,375$054,375IBy Perimetre Capital, LLC(3)
Explanation of Responses:
1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.
2. This option vested immediately upon grant.
3. Perimetre Capital, LLC is an entity owned and managed by Mr. Enslin.
/s/ Jeffrey D. Enslin07/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)